VivaGel® Coated Condom

The active ingredient of VivaGel®, SPL7013, has been shown in scientific studies to inactivate and inhibit infection with viruses, including HIV and the genital herpes virus.

 

Starpharma has a licence agreement with condom manufacturer Ansell Limited (ASX: ANN) to develop a VivaGel®-coated antiviral condom, and a licence agreement with Okamoto Industries Inc in relation to the VivaGel®-coated condom for the Japanese market. Okamoto is the market leader for condoms sold in Japan, the world’s second largest condom market. Starpharma will receive royalty and other payments from the agreements, and the coated condoms will carry the VivaGel® brand.

 

 


 

 

 

 

 

 

Condom_Stack.jpg

© Starpharma Holdings Limited 2014